(Q38572760)

4 September 2017

1 reference

title

Heparin-induced aldosterone suppression and hyperkalemia (English)

1 reference

4 September 2017

Oster JR

1

1 reference

4 September 2017

Singer I

series ordinal

2

1 reference

4 September 2017

Fishman LM

series ordinal

3

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

American Journal of Medicine

4 September 2017

published in

1 reference

4 September 2017

volume

98

1 reference

4 September 2017

issue

6

1 reference

4 September 2017

page(s)

575-586

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

4 September 2017

1 reference

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Adrenal hemorrhage complicating anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Routine Heparin Therapy Inhibits Adrenal Aldosterone Production*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Suppression of aldosterone production by low-dose heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Dose dependent suppression of mineralocorticoid metabolism by different heparin fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Inhibition by heparinoid of aldosterone biosynthesis in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Effect of a sulfated mucopolysaccharide (R01-8307) on the zona glomerulosa of the rat adrenal gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

The natriuretic action of heparin and some related substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Effect of heparinoid and spirolactone on the renal excretion of sodium and aldosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

The effect of heparin on sodium conservation and on the plasma concentration, the metabolic clearance and the secretion and excretion rates of aldosterone in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

The effect of heparin on aldosterone secretion and metabolism in primary aldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Low molecular weight heparins and hypoaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Excretion pattern and mechanism of diuresis induced by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Antihypertensive action of heparin: role of the renin-angiotensin aldosterone system and prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Effects of routine heparin therapy on plasma aldosterone concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

SELECTIVE HYPOALDOSTERONISM AFTER PROLONGED HEPARIN ADMINISTRATION. A CASE REPORT, WITH POSTMORTEM FINDINGS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Heparin-induced hyperkalemia: report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Heparin Side Effects-Reply.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

THE NATRIURETIC AND ALDOSTERONE-SUPPRESSIVE ACTION OF HEPARIN AND SOME RELATED POLYSULFATED POLYSACCHARIDES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Serum lipids and lipoproteins in diabetic glomerulosclerosis; preliminary observations of the effect of heparin upon the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

EFFECT OF HEPARIN AND HEPARINOIDS ON THE SYNTHESIS OF ALDOSTERONE AND CORTICOSTERONE BY THE RAT ADRENAL GLAND

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

The effect of a sulphated mucopolysaccharide (RO1-8307) on adrenal and kidney morphology and function in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Unlike heparin, low-molecular weight heparin does not suppress aldosterone production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Inhibition of renin by heparin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

"Binding" of a synthetic polypeptide (hypertensin) by heparin and in vitro liberation of the peptide by compound 48/80

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Direct effects of heparin on basal and stimulated aldosterone production in rat adrenal glomerulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Effects of a sulfated mucopolysaccharide (R01-8307) on zona glomerulosa width and steroid production by the rat adrenal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Studies on aldosterone biosynthesis in vitro. II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Examination of the mechanisms whereby heparin impairs aldosterone biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Loci of Action of Regulators of Aldosterone Biosynthesis in Isolated Glomerulosa Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Effect of a sulfated mucopolysaccharide (RO 1-8307) on the zona glomerulosa of regenerating rat adrenal glands and of intact glands in sodium-deprived rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Chlorbutol, a new inhibitor of aldosterone biosynthesis identified during examination of heparin effect on aldosterone production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Heparin-induced hyperkalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Heparin-induced hyperkalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Drug-induced hyperkalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

Inhibition of adrenal function in man by heparin or heparinoid Ro 1-8307.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

7 January 2021

Quiz of the month: Hyponatremia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

7 January 2021

Heparinoid-induced inhibition of aldosterone secretion in pregnant women. The role of augmented aldosterone secretion in sodium conservation during normal pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

7 January 2021

Effect of angiotensin II on aldosterone and its precursor steroid production in adrenal zona glomerulosa cells from heparin-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980017-5

7 January 2021

10.1016/S0002-9343(99)80017-5

Identifiers

DOI

1 reference

4 September 2017

1 reference